1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > St Jude Medical Device Company Intelligence Report

St Jude Medical Device Company Intelligence Report

  • July 2013
  • -
  • Espicom Business Intelligence
  • -
  • 46 pages

St Jude Medical develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiology, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation medical devices for the management of chronic pain. The company operates through four operating segments:


Cardiac Rhythm Management (CRM) – tachycardia implantable cardioverter defibrillator systems (ICDs) and bradycardia pacemaker systems (pacemakers);
Cardiovascular – vascular products (including vascular closure devices, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, vascular plugs and other vascular accessories) and structural heart products (including heart valve replacement and repair products and structural heart defect devices);
Atrial Fibrillation (AF) – electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems; and
Neuromodulation – neurostimulation devices (including spinal cord stimulation and deep brain stimulation devices).
St Jude Medical has significantly expanded its product portfolio via its own internal development programmes and through strategic acquisitions. Its latest purchases include: AGA Medical Holdings, which boosted the company’s structural heart leadership with programmes across all major categories that include structural heart defects, left atrial appendage (LAA) occlusion, transcatheter aortic valve implantation (TAVI) and percutaneous mitral valve repair (PMVR); and LightLab Imaging, which positioned the company as the first to launch the only OCT product line to compete in the market for intravascular ultrasound (IVUS) imaging technology. St Jude Medical also invested in CardioMEMS, a company that has developed a wireless sensing and communication technology to assess cardiac performance. St Jude Medical has an exclusive option to acquire CardioMEMS if the company meets certain milestones.

In 2010, St Jude reported a 10% increase in sales to US$5.2 billion. Sales were also up 10% in the first six months of 2011. The company has approximately 15,000 employees and sells its products in more than 100 countries around the world; its largest geographic markets are the US, Europe and the Asia Pacific region, including Japan.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches
Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments

Divestments

Litigation

Key Corporate Events

Table Of Contents

St Jude Medical Device Company Intelligence Report
Contents

OVERVIEW 1

STRATEGIC FOCUS 3
CATD Growth Programme 4
Vascular Growth Programme 4
Structural Heart Growth Programme 5
Espicom View 5

FINANCIAL REVIEW 6
2012 Financial Results 6
CRM 8
Cardiovascular 8
AF 8
Neuromodulation 8
Five-Year Financial Data 9
Outlook 10
Employees 10

PRODUCTS 11
Cardiac Rhythm Management 11
Competition 11
ICD and CRT-D Devices 11
Recent Updates 12
Pacemakers 15
Recent Updates 15
Programmers and Remote Monitoring Devices 15
Recent Updates 16
Cardiovascular 17
Competition 17
Recent Updates 18
Atrial Fibrillation 20
Competition 20
Recent Updates 22
Neuromodulation 22
Competition 22
Recent Updates 23

RESEARCH AND DEVELOPMENT 25
Studies and Trials 26
Renal Denervation 26
EnligHTN I 26
MultiPoint Pacing 27
Fractional Flow Reserve 27
ILUMIEN I 27
FAME II 27
Cost Utility Analysis 28
Amplatzer 29
Peripheral Nerve Stimulation 30
Riata Leads 30
Accent MRI Pacemaker 31
Deep Brain Stimulation 31

MANUFACTURING AND DISTRIBUTION 32
Agreements Summary 33
Mergers and Acquisitions Summary 35
Abbott Laboratories 33
Zonare Medical Systems 33
Hansen Medical 33

MERGERS AND ACQUISITIONS 35
AGA Medical 35
LightLab Imaging 35
Northstar Neuroscience 36
Cardio Life Research 36
MediGuide 36
Radi Medical Systems 37

MINORITY INVESTMENTS 38
Spinal Modulation 38
Nanostim 38
iRhythm Technologies 38
CardioMEMS 39

DIVESTITURES 40
Venture Wire Control Catheter Product Line 40
Conor Medical 40
Medtel 40
Cardiac Assist Division 40

LITIGATION 41
Shareholders Lawsuit 41
Kenesy Nash 41
Silzone Litigation 41
Volcano Corporation and LightLab Imaging Inc 42
Volcano Corporation and St Jude Medical 42
Occlutech 43
AorTech 44

KEY CORPORATE EVENTS 45



List of Tables

Recent Key Events 2
St Jude Medical - Annual Financial Results, 2008-2012 6
St Jude Medical - Annual Revenues by Geographic Area, 2008-2012 6
St Jude Medical - Annual Revenues by Business Segment, 2008-2012 7
St Jude Medical - Annual CRM Sales, 2008-2012 8
St Jude Medical - Annual Cardiovascular Sales, 2008-2012 8
St Jude Medical - Five-Year Financial Summary 9
St Jude Medical - Key ICD/CRT-D Devices 11
St Jude Medical - Key Pacemaker Devices 15
St Jude Medical - Key Programmers and Remote Monitoring Devices 16
St Jude Medical - Key Cardiovascular Devices 17
St Jude Medical - Key Atrial Fibrillation Devices 21
St Jude Medical - Key Neuromodulation Devices 23
St Jude Medical - Annual RandD Expenditure, 2008-2012 25
St Jude Medical - Planned Product Launches, 2013 25



List of Charts

St Jude Medical - Annual Sales and Operating Income, 2008-2012 6
St Jude Medical - Annual Sales by Geographic Area, 2008-2012 7
St Jude Medical - Annual Sales by Business Area, 2008-2012 7
St Jude Medical - 2012 Sales by Business Area 11
Forecast 2013 Worldwide EP Market 20

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.